Chemotherapy resistance in osteosarcoma: current challenges and future directions

AJ Chou, R Gorlick - Expert review of anticancer therapy, 2006 - Taylor & Francis
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …

Chemotherapy resistance in osteosarcoma: current challenges and future directions.

AJ Chou, R Gorlick - Expert Review of Anticancer Therapy, 2006 - europepmc.org
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …

[引用][C] Chemotherapy resistance in osteosarcoma: current challenges and future directions

C AJ - Expert Rev Anticancer Ther, 2006 - cir.nii.ac.jp
Chemotherapy resistance in osteosarcoma : current challenges and future directions | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Chemotherapy resistance in osteosarcoma: current challenges and future directions

AJ Chou, R Gorlick - Expert Review of Anticancer Therapy, 2006 - go.gale.com
Mummified remains over 5000 years old show the existence of osteosarcoma (OS) in
ancient Egyptians [1]. Although amputation was a documented form of surgical intervention …

Chemotherapy resistance in osteosarcoma: current challenges and future directions

AJ Chou, R Gorlick - Expert review of anticancer therapy, 2006 - pubmed.ncbi.nlm.nih.gov
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …

Chemotherapy resistance in osteosarcoma: Current challenges and future directions

AJ Chou, R Gorlick - Expert Review of Anticancer …, 2006 - einstein.elsevierpure.com
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …

Chemotherapy resistance in osteosarcoma: Current challenges and future directions

AJ Chou, R Gorlick - Expert review of anticancer …, 2006 - mdanderson.elsevierpure.com
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …

[引用][C] Chemotherapy resistance in osteosarcoma: current challenges and future directions

AJ Chou, R Gorlick - Expert Review of Anticancer Therapy, 2006 - cir.nii.ac.jp
Chemotherapy resistance in osteosarcoma: current challenges and future directions | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[引用][C] Chemotherapy resistance in osteosarcoma: current challenges and future directions

AJ CHOU, R GORLICK - Expert review of anticancer therapy, 2006 - Future Drugs